The 20 Best Follicular Lymphoma Doctors Near Me in Michigan, US

Mark Kaminski is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Kaminski is rated as an Elite provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Gastric Lymphoma, and Bone Marrow Aspiration.

Mohammad Chisti is a Hematologist and an Oncologist practicing medicine in Troy, Michigan. He has been practicing medicine for over 21 years. Dr. Chisti is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 100 other conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Chronic Myelogenous Leukemia (CML), Anemia, Bone Marrow Aspiration, and Gastrostomy. Dr. Chisti is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Chisti is currently accepting new patients.

Brett Brinker is a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 26 years. Dr. Brinker is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 60 other conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Brinker is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brinker is currently accepting new patients.

Latha Polavaram is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 27 years. Dr. Polavaram is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. She is also highly rated in 73 other conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Polavaram is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Polavaram is currently accepting new patients.

Erin Pettijohn is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 15 years. Dr. Pettijohn is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Pettijohn is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Pettijohn is currently accepting new patients.

Dr. Malek is a physician scientist and professor of hematology/oncology working at the University of Michigan, Ann Arbor, USA. He obtained his MD from the University of Hamburg/Germany and subsequently trained in Molecular Biology at Johns Hopkins. He completed clinical training in Internal Medicine at Baylor College of Medicine and a combined fellowship in Hematology and Oncology at Johns Hopkins and Columbia University. Dr. Malek is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Malek is board certified in Hematology.

Dr. Carty completed her undergraduate work at Harvard University, graduating magna cum laude, with a degree in Biochemical Sciences. She attended the Albert Einstein College of Medicine in New York where she earned her MD degree. Dr. Carty stayed in New York for her internal medicine residency at Columbia University Medical Center, and moved to the Hospital of the University of Pennsylvania for her Hematology-Oncology fellowship. She remained on staff at the Hospital of the University of Pennsylvania before moving here to Ann Arbor. Dr. Carty is the recipient of a K08 Award for her work in T cell biology and ASH Scholar Award for her research on T cell lymphomas. Dr. Carty is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Carty is board certified in Hematology.

Monalisa Ghosh, MD, Assistant Professor. Dr. Ghosh graduated with honors from the University of Alabama at Birmingham with a BS in Biomedical Engineering, minor in Mathematics and Chemistry. She earned her MD from the University of Alabama School of Medicine where she also completed her residency training. Her fellowship training was completed at the NIH/NCI Medical Oncology Fellowship Program. Dr. Ghosh’s research interest is in bone marrow trans-plantation and cellular therapies to treat lymphoma. Dr. Ghosh will be seeing patients on the BMT service. Dr. Ghosh is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Graft Versus Host Disease (GvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Colonoscopy.

The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.

Zachary Hector is a Hematologist Oncology provider practicing medicine in Traverse City, Michigan. He has been practicing medicine for over 22 years. Dr. Hector is rated as a Distinguished provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Hector is board certified in American Board Of Internal Medicine, Medical Oncology - 2013 and American Board Of Internal Medicine, Hematology - 2013. Dr. Hector is currently accepting new patients.

Mohammad Alhyari is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 18 years. Dr. Alhyari is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Alhyari is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Alhyari is currently accepting new patients.

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

Paul Thieme is a Radiation Oncologist practicing medicine in Holland, Michigan. He has been practicing medicine for over 38 years. Dr. Thieme is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Prostate Cancer, Familial Prostate Cancer, and Breast Cancer. Dr. Thieme is board certified in American Board Of Radiology. Dr. Thieme is currently accepting new patients.

Matthew Cotant is a Hematologist and an Oncologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 25 years. Dr. Cotant is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Neuroendocrine Tumor, Lynch Syndrome, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Cotant is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Cotant is currently accepting new patients.

Kathryn Alguire is a Hematologist Oncology specialist and an Oncologist practicing medicine in Norton Shores, Michigan. She has been practicing medicine for over 27 years. Dr. Alguire is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Alguire is board certified in American Board Of Internal Medicine. Dr. Alguire is currently accepting new patients.

William Fabricius is an Otolaryngologist and a Hematologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 24 years. Dr. Fabricius is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Inflammatory Breast Cancer. Dr. Fabricius is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Fabricius is currently accepting new patients.

Edmund Paloyan is an Oncologist practicing medicine in Saint Joseph, Michigan. He has been practicing medicine for over 34 years. Dr. Paloyan is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 76 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Breast Cancer, and Lynch Syndrome. Dr. Paloyan is board certified in American Board Of Internal Medicine. Dr. Paloyan is currently accepting new patients.

Oscar Signori is an Oncologist practicing medicine in Dearborn, Michigan. He has been practicing medicine for over 52 years. Dr. Signori is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Thrombocytopenia, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Signori is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Signori is currently accepting new patients.

Mitchell Folbe is an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 34 years. Dr. Folbe is rated as an Advanced provider by MediFind in the treatment of Follicular Lymphoma. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Hemochromatosis, Angiosarcoma, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Folbe is board certified in American Board Of Internal Medicine. Dr. Folbe is currently accepting new patients.